year 24, Issue 94 (7-2025)
J. Med. Plants 2025, 24(94): 46-58 |
Back to browse issues page
Ethics code: IR.RUMS.RUC.1401.015
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Basirat E, Karimifard M, Ayoobi F, Jamali Z, Sadeghi T. The effect of Achillea millefolium a widely used plant in Persian Medicine on hemoglobin glycosylate and neuropathy symptoms in type 2 diabetic patients: A randomized clinical trial. J. Med. Plants 2025; 24 (94) :46-58
URL: http://jmp.ir/article-1-3706-en.html
URL: http://jmp.ir/article-1-3706-en.html
1- Medical Surgical Nursing Student, Student Research Committee, School of Nursing and Midwifery, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
2- Department of Internal Medicine, School of Medicine; Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
3- Occupational Safety and Health Research Center, NICICO, World Safety Organization and Rafsanjan University of Medical Sciences, Rafsanjan, Iran
4- Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
5- Department of Pediatric Nursing, School of Nursing and Midwifery; Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran ,t.sadeghi@rums.ac.ir
2- Department of Internal Medicine, School of Medicine; Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
3- Occupational Safety and Health Research Center, NICICO, World Safety Organization and Rafsanjan University of Medical Sciences, Rafsanjan, Iran
4- Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
5- Department of Pediatric Nursing, School of Nursing and Midwifery; Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran ,
Abstract: (77 Views)
Background: Diabetic neuropathy is a prevalent microvascular complication that significantly impairs patients' quality of life. Objective: This study examined the therapeutic effect of Achillea millefolium oral supplementation on glycated hemoglobin (HbA1C) levels and neuropathic symptoms in individuals suffering from type 2 diabetes. Method: In a triple-blind randomized clinical trial, 70 patients with type 2 diabetes attending a diabetes clinic in Rafsanjan were enrolled through convenience sampling and placed into intervention and placebo groups using the minimization technique. The patients in the intervention group received one capsule having 500 mg of aqueous extract of A. millefolium. They used the capsules daily for three months. The patients in the placebo group received identically appearing capsules filled with 500 mg of cellulose. Outcomes were assessed with the Michigan Neuropathy Screening Instrument (MNSI) and HbA1C testing, both administered at baseline and after the 3-month intervention period. The data were processed using SPSS-22 software. Results: Post-intervention analysis revealed a decrease in HbA1C levels in the A. millefolium group in comparison with the placebo group, but no significant intergroup difference was observed (P = 0.17). However, the participants in the intervention group showed a significant improvement in neuropathy symptoms relative to the placebo group (P = 0.001). Conclusions: The findings suggest that oral administration of Achillea millefolium can effectively alleviate neuropathic symptoms in patients with type 2 diabetes. Nevertheless, further clinical studies need to explore its potential effects on glycemic control.
Type of Study: Research |
Subject:
Medicinal Plants
Received: 2024/07/25 | Accepted: 2025/05/18 | Published: 2025/07/1
Received: 2024/07/25 | Accepted: 2025/05/18 | Published: 2025/07/1
References
1. Roden M and Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019; 576(7785): 51-60; [DOI:10.1038/s41586-019-1797-8]
2. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Song X, Ren Y and Shan P-F. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci. Rep. 2020; 10(1): 14790; [DOI:10.1038/s41598-020-71908-9]
3. Azadnajafabad S, Mohammadi E, Aminorroaya A, Fattahi N, Rezaei S, Haghshenas R, Rezaei N, Naderimagham Sh, Larijani B and Farzadfar F. Non-communicable diseases' risk factors in Iran; a review of the present status and action plans. J. Diabetes Metab. Disord. 2021; 23(2): 1-9; [DOI:10.1007/s40200-020-00709-8]
4. Mezil SA and Abed BA. Complication of diabetes mellitus. Annals of the Romanian Society for Cell Biology. 2021; 25(3): 1546-56.
5. Wang Y, Li W, Peng W, Zhpu J and Liu Z. Acupuncture for postherpetic neuralgia: Systematic review and meta-analysis. Medicine. 2018; 97(34): e11986. [DOI:10.1097/MD.0000000000011986]
6. Visser NA, Notermans NC, Linssen RS, van den Berg LH and Vrancken AFJE. Incidence of polyneuropathy in Utrecht, the Netherlands. Neurol. 2015; 84(3), 259-264; [DOI:10.1212/WNL.0000000000001160]
7. Hanewinckel R, Drenthen J, Oijenet M, Hofman A, van Doorn PA and Ikram MA. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurol. 2016; 87(18): 1892-1898. [DOI:10.1212/WNL.0000000000003293]
8. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice ASC, Stacey BR, Treede R-D, Turk DC and Wallace MS. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007; 5; 132(3): 237-51. [DOI:10.1016/j.pain.2007.08.033]
9. Backonja MM and Stacey B. Neuropathic pain symptoms relative to overall pain rating. J. Pain. 2004; 5(9): 491-7. [DOI:10.1016/j.jpain.2004.09.001]
10. Hanewinckel R, van Oijenet M, Arfan Ikram M and van Doorn P. The epidemiology and risk factors of chronic polyneuropathy. Eur. J. Epidemiol. 2016; 31(1): 5-20. [DOI:10.1007/s10654-015-0094-6]
11. Callaghan BC, Cheng HT, Stables CL, Smith AL and Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012; 11(6): 521-34. [DOI:10.1016/S1474-4422(12)70065-0]
12. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann. Intern. Med. 1995; 122(8): 561-8. [DOI:10.7326/0003-4819-122-8-199504150-00001]
13. Medagama AB and Bandara R. The use of complementary and alternative medicines (CAMs) in the treatment of diabetes mellitus: is continued use safe and effective? Nutr. J. 2014; 13: 1-9. [DOI:10.1186/1475-2891-13-102]
14. Saarto T and Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Db. Syst. Rev. 2007; 4: CD005454. [DOI:10.1002/14651858.CD005454.pub2]
15. Eardley S, Bishop FL, Prescott P, Cardini F, Brinkhaus B, Santos-Rey K, Vas J, von Ammon K, Hegyi G, Dragan S, Uehleke B, Fønnebø V and Lewith G. A systematic literature review of complementary and alternative medicine prevalence in EU. Forsch Komplementmed. 2012; 19 (Suppl. 2): 18-28; [DOI:10.1159/000342708]
16. Dall'Acqua S, Bolego C, Cignarell A, Gaion RM and Innocenti G. Vasoprotective activity of standardized Achillea Millefolium extract. Phytomedicine. 2011; 18(12): 1031-1036; [DOI:10.1016/j.phymed.2011.05.005]
17. Li Y, Zhu MC, Zhang ML, Zhang M-L, Wang Y-F, Dong M, Shi Q-W, Huo Ch-H, Sauriol F, Kiyota H, Gu Y-Ch and Cong B. Achillinin B and C, new sesquiterpene dimers isolated from Achillea millefolium. Tetrahedron Lett. 2012; 53(21), 2601-2603. [DOI:10.1016/j.tetlet.2012.03.039]
18. Ramírez-Espinos JJ, Yolanda Rios M, López-Martínezet S López-Vallejo F, Medina-Franco JK, Paoli P, Camici G, Navarrete-Vázquez G, Ortiz-Andrade R and Estrada-Soto S. Antidiabetic activity of some pentacyclic acid triterpenoids, the role of PTP-1B: In vitro, in silico, and in vivo approaches. Eur. J. Med. Chem. 2011; 46(6): 2243-2251; [DOI:10.1016/j.ejmech.2011.03.005]
19. Akram M. Minireview on Achillea millefolium Linn. J. Membr. Biol. 2013; 246(9): 661-3. [DOI:10.1007/s00232-013-9588-x]
20. Chen J, Mangelinckx S, Adams A, Wang Zh-t, Li W-I and De Kimpe N. Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications. Nat. Prod. Commun. 2015; 10: 187-200. [DOI:10.1177/1934578X1501000140]
21. Gaikwad S, Krishna Mohan G, Sandhya Rani M. Phytochemicals for diabetes management. Pharm. Crops. 2014; 5: 11-28. [DOI:10.2174/2210290601405010011]
22. Putta S, Sastry Yarla N, Kumar Kilari E, Surekha C, Aliev G, Divakara MB, Santosh MS, Ramu R, Zameer F, Prasad Mn N, Chintala R, Rao PV, Shiralgi Y and Dhananjaya BL. Therapeutic potentials of triterpenes in diabetes and its associated complications. Curr. Top. Med. Chem. 2016; 16(23): 2532-2542. [DOI:10.2174/1568026616666160414123343]
23. Zheng Y, Bai L, Zhou Y, Tong R, Zeng M, Li X and Shi J. Polysaccharides from Chinese herbal medicine for anti-diabetes recent advances. Int. J. Biol. Macromol. 2019; 121: 1240-1253. [DOI:10.1016/j.ijbiomac.2018.10.072]
24. De Souza P, Gasparotto Jr A, Crestani S, Stefanello MEA, Marques MCA, da Silva-Santos JE and Kassuya CAL. Hypotensive mechanism of the extracts and artemetin isolated from Achillea millefolium L. (Asteraceae) in rats. Phytomedicine. 2011; 18(10): 819-25. [DOI:10.1016/j.phymed.2011.02.005]
25. Vahid S, Dashti-Khavidaki S, Ahmadi F, Amini M and Salehi Surmaghi MH. Effect of herbal medicine Achillea millefolium on plasma nitrite and nitrate levels in patients with chronic kidney disease: A preliminary study. Iran. J. Kidney Dis. 2012; 5(6): 350-4.
26. Karimi A, Niazkar HR, Azar PS, Tutunchi H, Karimi M, Asghariazar V and Kooshki F. Protective effect of hydro-alcoholic extract of Achillea millefolium on renal injury and biochemical factors in streptozotocin-induced diabetic rats. Nutrition & Food Science. 2021; 18; 51(7): 1068-83; [DOI:10.1108/NFS-11-2020-0437]
27. Chávez-Silva F, Cerón-Romero L, Arias-Durán L, Navarrete-Vázquez G, Almanza-Pérez J, Román-Ramos R, Ramírez-Ávila G, Perea-Arango I, Villalobos-Molina R and Estrada-Soto S. Antidiabetic effect of Achillea millefollium through multitarget interactions: α-glucosidases inhibition, insulin sensitization, and insulin secretagogue activities. J. Ethnopharmacol. 2018; 15(212): 1-7. oi: 10.1016/j.jep.2017.10.005. [DOI:10.1016/j.jep.2017.10.005]
28. Nasrabadi Z, Rakhshani MH, Ebadi H, Akbarzadeh R. Comparison of the effect of gabapentin and evening primrose oil on peripheral neuropathy pain in patients with type 2 diabetes. Avice. J. Clin Med. 2019; 26(1): 5-11. [DOI:10.29252/ajcm.26.1.5]
29. Pandis N. Randomization. Part 2: minimization. Am. J. Orthod. Dentofac. Orthop. 2011; 140(6): 902-4; [DOI:10.1016/j.ajodo.2011.08.016]
30. Barnes J, Anderson LA, Phillipson JD. Herbal Medicines. 2007, Third ed Pharmaceutical Press, London; Grayslake, IL.
31. Ayoobi F, Moghadam-Ahmadi A, Amiri H, Vakilian AR, Heidari M, Farahmand H, Sheikh Fathollahi M, Fatemi I, Shafiei SA, Alahtavakoli M and Shamsizadeh A. Achillea millefolium is beneficial as an add-on therapy in patients with multiple sclerosis: A randomized placebo-controlled clinical trial. Phytomedicine. 2019; 52: 89-97. [DOI:10.1016/j.phymed.2018.06.017]
32. Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers, Feldman EL; DCCT/EDIC Research Group. Use of the Michigan neuropathy screening instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the diabetes control and complications trial/epidemiology of diabetes interventions and complications. Diabet. Med. 2012; 29(7): 937-44. [DOI:10.1111/j.1464-5491.2012.03644.x]
33. Fateh HR, Madani SP, Heshmat R and Larijani B. Correlation of Michigan neuropathy screening instrument, the United Kingdom screening test, and electrodiagnosis for early detection of diabetic peripheral neuropathy. J. Diabet & Metabolic Disorders. 2015; 15(8). [DOI:10.1186/s40200-016-0229-7]
34. Sadeghi H, Radmanesh E, Akbartabar Turi M, Mohammadi R and Nazem H. Hypoglycemic effects of Achillea wilhelmsii in normal and streptozotocin-induced diabetic rats. Armaghane Danesh Bimonth. J. 2009; 14(1): 92-9.
35. Akramian Fard M, Moghaddam Ahmadi A, Ayyobi F, Nakisa H, Hadadian Z, Shabani M, Tavakoli MA and Shamsi zadeh A. Effects of Achillea millefolium aqueous extract in a Parkinson's disease model induced by intra-cerebral-ventricular injection of 6-hydroxydopamine in male rats. JSUMS. 2015; 22(1): 36-44.
36. Vazirinejad R, Ayoobi F, Kazemi Arababadi M, Eftekharian MM, Darekordi A, Goudarzvand M, Hassanshahi GhH, Taghavi MM, Nasiri Ahmadabadi B, Kennedy D and Shamsizadeh A. Effect of aqueous extract of Achillea millefolium on the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. Indian J. Pharmacol. 2014; 46(3): 303-8. [DOI:10.4103/0253-7613.132168]
37. Benedek B, Kopp B and Melzig MF. Achillea millefolium L. sl-Is the anti-inflammatory activity mediated by protease inhibition. J. Ethnopharmacol. 2007; 113(2): 312-7. [DOI:10.1016/j.jep.2007.06.014]
38. Kbaydet O, Abou-Ela M and Raafat K. Achillea extracts elicit anti-diabetic neuropathic pain by modulating inflammatory cytokines. JTCM. 2024; [DOI:10.1016/j.jtcme.2024.04.012]
39. Bathaie SZ, Mokarizade N and Shirali S. An overview of the mechanisms of plant ingredients in the treatment of diabetes mellitus. J. Med Plants. 2012; 10; 11(44): 1-24.
40. Cao G, Booth SL, Sadowski JA and Prior RL. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am. J. Clin. Nutr. 1998; 68(5): 1081-7; [DOI:10.1093/ajcn/68.5.1081]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
